Search filters

List of works by David Jamieson

A novel imaging flow cytometry method for the detection of histone H4 acetylation in myeloid cells

scientific article published on 08 April 2019

A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours

scientific article published on 28 September 2016

Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo

scientific article published on 11 October 2012

Condensin II mutation causes T-cell lymphoma through tissue-specific genome instability

scientific article

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma

scientific article published on 11 January 2016

Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers

scientific article published on 25 November 2019

Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma.

scientific article published on 17 April 2009

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

scientific article published on 4 September 2017

Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the "European Paediatric Oncology Off-patents Medicines Consortium" (EPOC) Trial

scientific article published on 24 January 2020

Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer

scientific article published on 7 January 2016

High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers

scientific article published on 14 July 2015

Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity.

scientific article published on 10 January 2014

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

scientific article published on 27 April 2016

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.

scientific article

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

scientific article published on 01 May 2018

Institutional profile: pharmacogenomics research at Newcastle University.

scientific article published in September 2012

Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation.

scientific article

NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism

scientific article published on 01 March 2007

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

scientific article

Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide.

scientific article published on 8 December 2016

Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil

scientific article published on 24 July 2014

Pharmacogenetics of genes across the doxorubicin pathway.

scientific article published on October 2011

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

scientific article published on 22 March 2016

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.

scientific article published on 26 May 2016

Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor

scientific article published on 10 October 2006

Temporary Single-Cell Coating for Bioprocessing with a Cationic Polymer

scientific article

The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide

scientific article published on 29 September 2011

Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy

scientific article published on 01 December 2011

Paulina is supported by:

About Paulina

Help